BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson MD, Sakurai T, Rainero I, Maj MC, Kukkonen JP. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics. Pharmaceuticals (Basel) 2017;10:E79. [PMID: 28991183 DOI: 10.3390/ph10040079] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Romigi A, Bari M, Liguori C, Izzi F, Rapino C, Nuccetelli M, Battista N, Bernardini S, Centonze D, Mercuri NB, Placidi F, Maccarrone M. CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study. CNS Neurol Disord Drug Targets 2020;19:142-7. [PMID: 32148204 DOI: 10.2174/1871527319666200309115602] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Swinton MK, Sundermann EE, Pedersen L, Nguyen JD, Grelotti DJ, Taffe MA, Iudicello JE, Fields JA. Alterations in Brain Cannabinoid Receptor Levels Are Associated with HIV-Associated Neurocognitive Disorders in the ART Era: Implications for Therapeutic Strategies Targeting the Endocannabinoid System. Viruses 2021;13:1742. [PMID: 34578323 DOI: 10.3390/v13091742] [Reference Citation Analysis]
4 Li G, Zhang K, Wang L, Cao C, Fang R, Liu P, Luo S, Liberzon I. The preliminary investigation of orexigenic hormone gene polymorphisms on posttraumatic stress disorder symptoms. Psychoneuroendocrinology 2019;100:131-6. [DOI: 10.1016/j.psyneuen.2018.09.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
6 Pourrahimi AM, Abbasnejad M, Esmaeili-mahani S, Kooshki R, Raoof M. Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats. Neuropeptides 2019;73:25-33. [DOI: 10.1016/j.npep.2018.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Steardo L Jr, Carbone EA, Menculini G, Moretti P, Steardo L, Tortorella A. Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review. Life (Basel) 2021;11:214. [PMID: 33803374 DOI: 10.3390/life11030214] [Reference Citation Analysis]
8 Harwell V, Fasinu PS. Pitolisant and Other Histamine-3 Receptor Antagonists-An Update on Therapeutic Potentials and Clinical Prospects. Medicines (Basel) 2020;7:E55. [PMID: 32882898 DOI: 10.3390/medicines7090055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Vigil JM, Stith SS, Diviant JP, Brockelman F, Keeling K, Hall B. Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions. Medicines (Basel) 2018;5:E75. [PMID: 29997343 DOI: 10.3390/medicines5030075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Patel VH, Karteris E, Chen J, Kyrou I, Mattu HS, Dimitriadis GK, Rodrigo G, Antoniades C, Antonopoulos A, Tan BK, Hillhouse EW, Ng A, Randeva HS. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection. Clin Sci (Lond) 2018;132:2547-64. [PMID: 30467191 DOI: 10.1042/CS20180150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Batalla-Martín D, Belzunegui-Eraso A, Miralles Garijo E, Martínez Martín E, Romaní Garcia R, Heras JSM, Lopez-Ruiz M, Martorell-Poveda MA. Insomnia in Schizophrenia Patients: Prevalence and Quality of Life. Int J Environ Res Public Health 2020;17:E1350. [PMID: 32093111 DOI: 10.3390/ijerph17041350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Franco R, Villa M, Morales P, Reyes-Resina I, Gutiérrez-Rodríguez A, Jiménez J, Jagerovic N, Martínez-Orgado J, Navarro G. Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage. Neuropharmacology 2019;152:58-66. [PMID: 30738036 DOI: 10.1016/j.neuropharm.2019.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
13 Papasavva M, Katsarou MS, Vikelis M, Mitropoulou E, Dermitzakis EV, Papakonstantinou S, Arvaniti C, Mitsikostas DD, Gozes I, Tsatsakis AM, Drakoulis N. Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population. J Mol Neurosci 2020;70:467-74. [PMID: 31768945 DOI: 10.1007/s12031-019-01439-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Lu G, Lee MT, Chiou L. Orexin‐mediated restoration of hippocampal synaptic potentiation in mice with established cocaine‐conditioned place preference. Addiction Biology 2018;24:1153-66. [DOI: 10.1111/adb.12672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Botticelli L, Micioni Di Bonaventura E, Ubaldi M, Ciccocioppo R, Cifani C, Micioni Di Bonaventura MV. The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions. Pharmaceuticals (Basel) 2021;14:293. [PMID: 33810221 DOI: 10.3390/ph14040293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Medina-Vera D, Rosell-Valle C, López-Gambero AJ, Navarro JA, Zambrana-Infantes EN, Rivera P, Santín LJ, Suarez J, Rodríguez de Fonseca F. Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer's Disease in a Preclinical Model: A Therapeutic Opportunity. Biology (Basel) 2020;9:E377. [PMID: 33167441 DOI: 10.3390/biology9110377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lauriola M, Carleton RN, Tempesta D, Calanna P, Socci V, Mosca O, Salfi F, De Gennaro L, Ferrara M. A Correlational Analysis of the Relationships among Intolerance of Uncertainty, Anxiety Sensitivity, Subjective Sleep Quality, and Insomnia Symptoms. Int J Environ Res Public Health 2019;16:E3253. [PMID: 31491841 DOI: 10.3390/ijerph16183253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
18 Berk K, Bzdega W, Konstantynowicz-Nowicka K, Charytoniuk T, Zywno H, Chabowski A. Phytocannabinoids-A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment. J Clin Med 2021;10:393. [PMID: 33498537 DOI: 10.3390/jcm10030393] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Berrendero F, Flores Á, Robledo P. When orexins meet cannabinoids: Bidirectional functional interactions. Biochemical Pharmacology 2018;157:43-50. [DOI: 10.1016/j.bcp.2018.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Nagappan A, Shin J, Jung MH. Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications. Int J Mol Sci 2019;20:E2109. [PMID: 31035653 DOI: 10.3390/ijms20092109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
21 Le TA, Dang AD, Tran AHT, Nguyen LH, Nguyen THT, Phan HT, Latkin CA, Tran BX, Ho CSH, Ho RCM. Factors Associated with Sleep Disorders among Methadone-Maintained Drug Users in Vietnam. Int J Environ Res Public Health 2019;16:E4315. [PMID: 31698771 DOI: 10.3390/ijerph16224315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
22 Alapafuja SO, Nikas SP, Ho TC, Tong F, Benchama O, Makriyannis A. Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor. Molecules 2019;24:E3559. [PMID: 31581433 DOI: 10.3390/molecules24193559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lu J, Huang ML, Li JH, Jin KY, Li HM, Mou TT, Fronczek R, Duan JF, Xu WJ, Swaab D, Bao AM. Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain. Schizophr Bull 2021;47:1310-9. [PMID: 33974073 DOI: 10.1093/schbul/sbab042] [Reference Citation Analysis]
24 Pourrahimi AM, Abbasnejad M, Raoof M, Esmaeili-Mahani S, Kooshki R. The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats. Peptides 2021;146:170651. [PMID: 34560171 DOI: 10.1016/j.peptides.2021.170651] [Reference Citation Analysis]
25 Yu Y, He AB, Liou M, Ou C, Kozłowska A, Chen P, Huang AC. The Paradoxical Effect Hypothesis of Abused Drugs in a Rat Model of Chronic Morphine Administration. J Clin Med 2021;10:3197. [PMID: 34361981 DOI: 10.3390/jcm10153197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]